| Tretinoin | Approved Investigational Nutraceutical | SMYD3 | 64754 |
downregulated | Tretinoin results in decreased expression of SMYD3 mRNA | 1q44 | |
| Tretinoin | Approved Investigational Nutraceutical | SNAI1 | 6615 |
downregulated | Tretinoin results in decreased expression of SNAI1 mRNA | 20q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | SNAI1 | 6615 |
upregulated | Tretinoin results in increased expression of SNAI1 mRNA | 20q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | SNAI2 | 6591 |
downregulated | Tretinoin results in decreased expression of SNAI2 mRNA | 8q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | SNAI2 | 6591 |
upregulated | Tretinoin results in increased expression of SNAI2 mRNA | 8q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | SNAI3-AS1 | 197187 |
upregulated | Tretinoin results in increased expression of SNAI3-AS1 mRNA | 16q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SNAP25 | 6616 |
upregulated | Tretinoin results in increased expression of SNAP25 mRNA | 20p12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SNAP91 | 9892 |
upregulated | Tretinoin results in increased expression of SNAP91 mRNA | 6q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SNCA | 6622 |
upregulated | Tretinoin results in increased expression of SNCA mRNA | 4q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SNCAIP | 9627 |
upregulated | Tretinoin results in increased expression of SNCAIP mRNA | 5q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SNHG15 | 285958 |
downregulated | Tretinoin results in decreased expression of SNHG15 mRNA | 7p13 | |
| Tretinoin | Approved Investigational Nutraceutical | SNN | 8303 |
upregulated | Tretinoin results in increased expression of SNN mRNA | 16p13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | SNORD104 | 692227 |
downregulated | Tretinoin results in decreased expression of SNORD104 mRNA | 17q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SNRNP200 | 23020 |
downregulated | Tretinoin results in decreased expression of SNRNP200 mRNA | 2q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SNRPA | 6626 |
downregulated | Tretinoin results in decreased expression of SNRPA mRNA | 19q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SNRPB | 6628 |
downregulated | Tretinoin results in decreased expression of SNRPB mRNA | 20p13 | |
| Tretinoin | Approved Investigational Nutraceutical | SNRPD1 | 6632 |
downregulated | Tretinoin results in decreased expression of SNRPD1 mRNA | 18q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SNTB1 | 6641 |
upregulated | Tretinoin results in increased expression of SNTB1 mRNA | 8q24.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SNX10 | 29887 |
downregulated | Tretinoin results in decreased expression of SNX10 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SNX21 | 90203 |
upregulated | Tretinoin results in increased expression of SNX21 mRNA | 20q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SNX22 | 79856 |
downregulated | Tretinoin results in decreased expression of SNX22 mRNA | 15q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | SNX5 | 27131 |
downregulated | Tretinoin results in decreased expression of SNX5 mRNA | 20p11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | SOCS1 | 8651 |
downregulated | Tretinoin metabolite results in decreased expression of SOCS1 mRNA | 16p13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | SOCS1 | 8651 |
downregulated | Tretinoin results in decreased expression of SOCS1 mRNA | 16p13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | SOCS2 | 8835 |
upregulated | Tretinoin metabolite results in increased expression of SOCS2 mRNA | 12q | |